Catalyst Biosciences, Inc.
General ticker "CBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.4M (TTM average)
Catalyst Biosciences, Inc. does not follow the US Stock Market performance with the rate: -19.8%.
Estimated limits based on current volatility of 8.5%: low 12.80$, high 15.18$
Factors to consider:
- Total employees count: 574 (-3.2%) as of 2024
- Top business risk factors: Dependence on ETUARY sales, Market acceptance, Market disruptions, Acquisition/divestiture risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.87$, 26.71$]
- 2025-12-31 to 2026-12-31 estimated range: [8.19$, 25.85$]
Financial Metrics affecting the CBIO estimates:
- Negative: with PPE of -39.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.06 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 41.86 < Shareholder equity ratio, % of 50.49 <= 63.39
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term CBIO quotes
Long-term CBIO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.01MM | $0.00MM |
| Operating Expenses | $47.48MM | $39.29MM | $68.76MM |
| Operating Income | $-47.40MM | $-39.28MM | $-68.76MM |
| Non-Operating Income | $0.71MM | $2.38MM | $-2.70MM |
| R&D Expense | $28.39MM | $20.07MM | $56.14MM |
| Income(Loss) | $-46.69MM | $-36.90MM | $-71.47MM |
| Profit(Loss)* | $-46.69MM | $-44.35MM | $-37.88MM |
| Stockholders Equity | $-21.69MM | $-15.83MM | $63.32MM |
| Assets | $28.44MM | $116.54MM | $125.41MM |
| Operating Cash Flow | $-33.10MM | $-34.88MM | $-31.10MM |
| Capital expenditure | $0.08MM | $0.02MM | $0.01MM |
| Investing Cash Flow | $55.43MM | $-0.02MM | $0.02MM |
| Financing Cash Flow | $-45.01MM | $28.82MM | $0.01MM |
| Earnings Per Share** | $-0.89 | $-0.70 | $-0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.